À propos de Manuelle
Cheffe des Opérations | Biotech & Pharma | Oncologie
Je transforme des actifs scientifiques prometteurs en programmes cliniques financés et opérationnellement solides.
Avec plus de 10 ans d'expérience à la tête des opérations de biotechs en oncologie, j'ai piloté des levées de fonds dépassant 6M£, structuré des plans de développement précliniques et cliniques, et géré des portefeuilles de projets à plusieurs millions d'euros — de la stratégie jusqu'à l'exécution terrain.
Ce que je fais mieux que quiconque :
- Faire le lien entre la science, la finance et l'opérationnel. Là où d'autres voient de la complexité, je vois un plan d'action.
- Direction des opérations bout-en-bout : pipeline scientifique, CROs, Board, parties prenantes, budget et runway.
- Création et structuration de sociétés biotech (spin-outs, business cases, decks investisseurs).
- Fundraising opérationnel : 4,2M£ levés chez Nodus Oncology, +2M£ chez Medannex/Oncobiopharm.
- Management de projets interdisciplinaires à fort enjeu (Wellcome Trust, MRC, SMART:Scotland). Leadership d'équipes expertes pluridisciplinaires (CMC, réglementaire, préclinique, clinique).
Formation entrepreneuriale à Babson College (Boston), PRINCE2 Practitioner, PhD en pharmacologie. Bilingue français–anglais.
Vous avez une molécule, un actif, ou une organisation à faire avancer ? Parlons-en.
Anglais
Bilingue ou natif
Français
Bilingue ou natif
Accepte de travailler sur site
Montpellier (jusqu’à 50 km)
Expériences
- Nodus Oncology Ltd,Operation's directorBIOTECHNOLOGIESseptembre 2022 - février 2025 (2 ans et 5 mois)Édimbourg, Royaume-Uni• - Operational and Scientific Leadership Management of the company's day to days operations including strategy execution, scientific pipeline management, Board of director preparations, stakeholder relationship supervision, and fundraising support• - Fundraising and competitive intelligence Distillation of scientific rationale and data, in accessible format, for the production of exciting fundraising deck and business plan to raise investor's interests. £4,2 millions raised in 2 tranches to bring our molecule to clinical candidate. Horizon scanning of the competitive landscape to identify main competitor and create a differentiation for our compound.• - Stakeholder management Working close to the CEO and the CFO to be agile with scientific planning and monitor delivery and timelines against the company's strategy, while ensuring financial health and anticipate the company's runway Working close to the scientific team and CROs to build-up and supervise the development plan's execution and successfully forecast the next phase of developmentAltogether maintaining open communication stream across the company, encouraging outside of the box thinking to successfully tackle difficult situations, human, scientific or financial.
- Cumulus Oncology Ltd,Director of Scientific AffairsBIOTECHNOLOGIESjanvier 2019 - février 2025 (6 ans et 1 mois)Édimbourg, Royaume-Uni• - Conducting due diligence for innovative asset opportunity to licenseReviewing data package and analysing market opportunity for asset available to license, with thepotential for further development in the oncology field. Coordination of the due diligence process within the team, gathering individual's recommendation and reporting of the conclusion on eachopportunity.• - Company creationBusiness case development for the creation of new companies around pipeline of asset focused on the same theme, including scientific development plan, competitive landscape and market positioning. Spin-out of Nodus Oncology is the first company from Cumulus Oncology, based on DDR assets and development of Nuan Bioscience (still in incubation – soon to be the third spin out), based mAbs and ADCs. Creation of fundraising deck and opportunity deck for each opportunity• - Scientific operations leadership Create preclinical development plan based on due diligence findings on innovative assets. Management external communication with CROs to plan activities and resources needed to reach value inflection point
- The University of Oxford BrookesEntrepreneurial Lead - iCURE ProgrammeCHIMIEjuin 2019 - septembre 2019 (3 mois)Oxford, Royaume-Uni• - Business development and investor engagement Conducting strategic analysis, market opportunity assessments and due diligence, for a technology enabling oral bioavailability rising from Oxford Brookes University. Business development andrelationship management internally with leading academics, and externally with investors, Pharma & biotech companies in the field to determine how to position the technology and source financialsupport. Preparing compelling communication materials including presentation for investors to find matchfunding to complement regional funding opportunity.
Recommandations
Soyez le premier à recommander Manuelle
Contribuez à la réussite de ce freelance en partageant votre expérience de collaboration avec lui.
Ces profils de freelance correspondent également à vos critères
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Formations
- Executive EducationBabson College2014Executive Education
- PRINCE2 Practitioner - Project Management qualificationAPMG-International2013PRINCE2 Practitioner - Project Management qualification